Comparison Chart Astellas Pharma Inc.

4503

JP3942400007

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ASTELLAS PHARMA INC.	Other Pharmaceuticals	+2.03%	+5.69%	+22.46%	+56.66%	+30.27%	28.72B

10-08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
10-08	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Delayed Japan Exchange 05:38:43 26/10/2026 GMT			5-day change	1st Jan Change
2,563.00 ^JPY	+2.03%		+5.69%	+22.46%

Comparison Chart Astellas Pharma Inc.

Stocks

4503

JP3942400007

Pharmaceuticals

Compared values